Physician profile
Peter L Naruns
NPI 1689636680
$924.54
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $735 · 2020: $190.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $176.77 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $112.06 | 2019 | |
| Amgen INC. | $83.98 | 2019 | |
| Incyte Corporation | $75.78 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $69.08 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.19 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $49.00 | 2019-2020 | |
| Janssen Biotech, INC. | $42.40 | 2019-2020 | |
| Intuitive Surgical, INC. | $38.70 | 2019 | |
| Seagen INC. | $29.82 | 2020 | |
| Foundation Medicine, INC. | $28.61 | 2019-2020 | |
| Blueprint Medicines Corporation | $24.97 | 2020 | |
| Amarin Pharma, INC. | $23.06 | 2020 | |
| Myriad Genetic Laboratories, INC. | $22.96 | 2019 | |
| Novo Nordisk INC | $19.51 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tesaro, INC. | $19.22 | 2019 | |
| Davol INC. | $18.80 | 2019 | |
| Celgene Corporation | $16.35 | 2019 | |
| Eisai INC. | $16.28 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Naruns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.